Polymeric biomaterials derived from phenolic monomers and their medical uses

US10774030B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10774030-B2
Application numberUS-201616065889-A
CountryUS
Kind codeB2
Filing dateJun 3, 2016
Priority dateDec 23, 2014
Publication dateSep 15, 2020
Grant dateSep 15, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are new classes of diphenol compounds, derived from tyrosol or tyrosol analogues and hydroxybenzoic acid, which are useful as monomers for preparation of biocompatible polymers. Also disclosed are biocompatible polymers prepared from these monomeric diphenol compounds, including novel biodegradable and/or bioresorbable polymers of formula. These biocompatible polymers or polymer compositions with enhanced bioresorbability and processibility are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic compositions. The invention also provides methods for preparing these monomeric diphenol compounds and biocompatible polymers.

First claim

Opening claim text (preview).

What is claimed is: 1. A biocompatible polymer, comprising a recurring unit of formula: wherein: j and k are each independently zero or an integer selected from 1 to 6, provided that j and k are not both 0; X 1 and X 2 are each independently bromine (Br) or iodine (I), and y 1 and y 2 are each independently 0, 1, 2, 3, or 4; L 1 is selected from the group consisting of oxygen (—O—), —R 4 —C(═O)—O—, and —O—R 4a —O—C(═O)—; wherein R 4 is selected from the group consisting of C 1 -C 30 alkylene, C 2 -C 30 alkenylene, C 2 -C 30 alkynylene, C 1 -C 30 heteroalkylene, C 2 -C 30 heteroalkenylene, C 2 -C 30 heteroalkynylene, C 6 -C 30 arylene, C 7 -C 30 alkylarylene, C 8 -C 30 alkenylarylene, C 8 -C 30 alkynylarylene, and C 2 -C 30 heteroarylene; and R 4a is selected from the group consisting of C 1 -C 30 alkylene, C 2 -C 30 alkenylene, C 2 -C 30 alkynylene, C 1 -C 30 heteroalkylene, C 2 -C 30 heteroalkenylene, C 2 -C 30 heteroalkynylene, C 6 -C 30 arylene, C 7 -C 30 alkylarylene, C 8 -C 30 alkenylarylene, C 8 -C 30 alkynylarylene, and C 2 -C 30 heteroarylene; L 4 is selected from the group consisting of a bond, and optionally substituted phenoxy (C 6 H 4 —O—); L 5 is a bond; Q 2 at each occurrence is independently hydrogen or halogen; or two adjacent Q 2 form a double bond when adjacent Qs are present; or Z 2 and an adjacent Q 2 form a double bond; Z 2 is hydrogen, —N(R x )C(═O)R 5 , —N(R x )COOR 6 , —C(O)OR 7 or —C(O)NR x R y , or Z 2 and an adjacent Q 2 form a double bond; wherein R 5 , R 6 , R 7 , R x and R y are independently at each occurrence selected from the group consisting of hydrogen, alkyl, aryl, alkylaryl, arylalkyl, heteroalkyl, and heteroalkylaryl, wherein the non-hydrogen groups contain up to 30 carbon atoms, wherein the heteroalkyl group contains from 1 to 10 heteroatoms independently selected from O, N and S, and the heteroalkylaryl group contains from 1 to 3 heteroatoms independently selected from O, N and S; and wherein A 1 is selected from the group consisting of: wherein R 8 is selected from a bond, C 1 -C 30 alkylene, C 2 -C 30 alkenylene, C 2 -C 30 alkynylene; C 1 -C 30 heteroalkylene, C 2 -C 30 heteroalkenylene, C 2 -C 30 heteroalkynylene, C 7 -C 30 heteroalkylarylene, C 8 -C 30 heteroalkenylarylene, C 8 -C 30 heteroalkynylarylene, C 7 -C 30 alkylarylene, C 8 -C 30 alkenylarylene, C 8 -C 30 alkynylarylene, and C 2 -C 30 heteroarylene; and wherein R 9 and R 10 are each independently selected from H, C 1 -C 30 alkyl, C 1 -C 30 heteroalkyl, C 2 -C 30 alkenyl, C 2 -C 30 alkynyl, C 2 -C 30 heteroalkenyl, and C 2 -C 30 heteroalkynyl. 2. A biocompatible polymer, comprising a recurring unit of formula: wherein: j and k are each independently zero or an integer selected from 1 to 6, provided that j and k are not both 0; X 1 and X 2 are each independently bromine (Br) or iodine (I), and y 1 and y 2 are each independently 0, 1, 2, 3, or 4; L 1 is selected from the group consisting of oxygen (—O—), —R 4 —C(═O)—O—, and —O—R 4a —O—C(═O)—; wherein R 4 is selected from the group consisting of C 1 -C 30 alkylene, C 2 -C 30 alkenylene, C 2 -C 30 alkynylene, C 1 -C 30 heteroalkylene, C 2 -C 30 heteroalkenylene, C 2 -C 30 heteroalkynylene, C 6 -C 30 arylene, C 7 -C 30 alkylarylene, C 5 -C 30 alkenylarylene, C 5 -C 30 alkynylarylene, and C 2 -C 30 heteroarylene; and R 4a is selected from the group consisting of C 1 -C 30 alkylene, C 2 -C 30 alkenylene, C 2 -C 30 alkynylene, C 1 -C 30 heteroalkylene, C 2 -C 30 heteroalkenylene, C 2 -C 30 heteroalkynylene, C 6 -C 30 arylene, C 7 -C 30 alkylarylene, C 5 -C 30 alkenylarylene, C 5 -C 30 alkynylarylene, and C 2 -C 30 heteroarylene; L 4 is selected from the group consisting of a bond, and optionally substituted phenoxy (—C 6 H 4 —O—); L 5 is a bond; Q 2 at each occurrence is independently hydrogen or halogen; or two adjacent Q 2 form a double bond when adjacent Qs are present; or Z 2 and an adjacent Q 2 form a double bond; Z 2 is hydrogen, —N(R x )C(═O)R 5 , —N(R x )COOR 6 , —C(O)OR 7 or —C(O)NR x R y , or Z 2 and an adjacent Q 2 form a double bond; wherein R 5 , R 6 , R 7 , R x and R y are independently at each occurrence selected from the group consisting of hydrogen, alkyl, aryl, alkylaryl, arylalkyl, heteroalkyl, and heteroalkylaryl, wherein the non-hydrogen groups contain up to 30 carbon atoms, wherein the heteroalkyl group contains from 1 to 10 heteroatoms independently selected from O, N and S, and the heteroalkylaryl group contains from 1 to 3 heteroatoms independently selected from O, N and S. 3. The biocompatible polymer of claim 1 , wherein L 1 is oxygen and L 4 is a bond, providing a recurring unit of formula: 4. The biocompatible polymer of claim 2 , wherein L 1 is oxygen and L 4 is a bond, providing a recurring unit of formula: 5. The biocompatible polymer of claim 1 , wherein L 1 is oxygen and L 4 is a bond, and Q 2 is hydrogen, providing a recurring unit of formula: 6. The biocompatible polymer of claim 2 , wherein L 1 is oxygen and L 4 is a bond, and Q 2 is hydrogen, providing a recurring unit of formula: 7. The biocompatible polymer of claim 6 , wherein the phenyl groups of the recurring unit have the phenolic oxygens in the para-position. 8. The biocompatible polymer of claim 6 , wherein L 4 is a bond, L 1 is oxygen, and Q 2 and Z 2 are both hydrogen. 9. The biocompatible polymer of claim 1 , wherein j=k=1, L 1 is oxygen, L 4 is a bond, and Q 2 and Z 2 are each hydrogen, providing a recurring unit of formula: 10. The biocompatible polymer of claim 2 , wherein j=k=1, L 1 is oxygen, L 4 is a bond, and Q 2 and Z 2 are each hydrogen, providing a recurring unit of formula: 11. The biocompatible polymer of claim 9 , wherein X 1 and X 2 are iodine, and one of y1 and y2 is non-zero. 12. The biocompatible polymer of claim 9 , wherein X 1 and X 2 are iodine, one of y1 and y2 is 2, and the phenyl groups of the recurring unit have the phenolic oxygens in the para-position. 13. The biocompatible polymer of claim 9 , which is a polycarbonate and further comprises a second recurring unit of optionally iodinated tyrosol. 14. A biocompatible polyurethane comprising an optionally iodinated tyrosine or an optionally iodinated tyrosine ester recurring unit, and a second recurring unit selected from the group consisting of HBA (hydroxybenzoic acid), mono-iodinated HBA and di-iodinated HBA. 15. A biocompatible copolymer comprising the recurring unit of the poly

Assignees

Inventors

Classifications

  • containing nitrogen · CPC title

  • Succinic acid esters · CPC title

  • having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton · CPC title

  • Oxalic acid esters · CPC title

  • the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10774030B2 cover?
Disclosed are new classes of diphenol compounds, derived from tyrosol or tyrosol analogues and hydroxybenzoic acid, which are useful as monomers for preparation of biocompatible polymers. Also disclosed are biocompatible polymers prepared from these monomeric diphenol compounds, including novel biodegradable and/or bioresorbable polymers of formula. These biocompatible polymers or polymer compo…
Who is the assignee on this patent?
Univ Rutgers
What technology area does this patent fall under?
Primary CPC classification C07C69/732. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).